GlassScriptPhysician profile
Sierra Lee
NPI 1700458437
$1,836.35
in general payments reported to CMS, 2019-2025
20 companies · $136 in 2025
The $136 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $185 · 2022: $441 · 2023: $499 · 2024: $575 · 2025: $136.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,211.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,210.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $382.89 | 2021-2025 | |
| Novo Nordisk INC | $356.47 | 2021-2025 | Rybelsus, Ozempic |
| Boehringer Ingelheim Pharmaceuticals, INC. | $237.65 | 2021-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $194.58 | 2021-2024 | Farxiga, Airsupra |
| Axsome Therapeutics, INC. | $129.94 | 2024 | Auvelity |
| Abbott Laboratories | $90.25 | 2024 | Freestyle Libre 3 |
| Pfizer INC. | $74.01 | 2021-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $56.83 | 2021-2023 | Trintellix |
| Glaxosmithkline, LLC. | $51.80 | 2022-2023 | Shingrix, Arexvy |
| Lilly USA, LLC | $46.00 | 2025 | Zepbound, Mounjaro |
| Amgen INC. | $38.72 | 2022-2024 | Repatha, Otezla |
| Biohaven Pharmaceutical Holding Company LTD. | $37.89 | 2022 | |
| Exact Sciences Corporation | $29.08 | 2023 | Cologuard Collection Kit |
| Dexcom, INC. | $20.39 | 2025 | Dexcom G6 Transmitter |
| Almatica Pharma LLC | $18.03 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $16.74 | 2024 | Veozah |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.85 | 2022 | |
| Tms Neurohealth Centers INC. | $13.78 | 2025 | Tms Neurohealth Centers INC. |
| Irhythm Technologies, INC. | $13.24 | 2024 | Zio Monitor, Zio Xt Patch |
| Amarin Pharma, INC. | $13.21 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sierra Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.